Study Stopped
Recruitment and Funding challenges
MRI of Lung Structure and Function in Preterm Children
1 other identifier
observational
12
1 country
1
Brief Summary
The MRI tools developed by the investigators are well positioned for assessing regional changes in lung structure and function in preterm children with bronchopulmonary dysplasia (BPD), in which airway limitation similar to asthma, alveolar simplification similar to emphysema and pulmonary vascular stunting are expected. To the investigator's knowledge, the combination of ultra short echo time (UTE) proton, pulmonary vascular proton and hyperpolarized 129Xe MRI have not yet been explored in BPD, either clinically or preclinically. The investigators propose that a comprehensive MRI examination may be useful from a diagnostic perspective, MRI of preterm children without BPD may reveal changes which are otherwise clinically 'silent' yet still place children at risk for future chronic lung disease in later life.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Sep 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 6, 2018
CompletedFirst Posted
Study publicly available on registry
March 23, 2018
CompletedStudy Start
First participant enrolled
September 1, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 8, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
October 8, 2019
CompletedAugust 1, 2025
July 1, 2025
1.1 years
February 6, 2018
July 29, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
MRI ventilation and 1H MRI thoracic cavity volume and tissue density
Ventilation defect percent (VDP) (%) will be generated for whole lung and individual lung slices using manual or semi-automated segmentation. For proton (1H) thoracic cavity images, the thoracic cavity volume (TCV) will be calculated by manual or semi-automated segmentation.
2 years
Secondary Outcomes (2)
Apparent Diffusion Coefficients (ADC) and ADC maps
2 years
Multiple breath washout testing:
2 years
Study Arms (3)
Healthy
Healthy Participants
BPD cohort
Participants born prematurely with a diagnosis of BPD
Non-BPD cohort
Participants born prematurely without a diagnosis of BPD
Interventions
Participants will be undergoing hyperpolarized xenon and proton lung MRI
Eligibility Criteria
Healthy volunteers will be selected from the general population and the BPD and non-BPD cohorts will be selected from patients from clinics seen at the Hospital for Sick Children, Toronto
You may qualify if:
- \- Children born pre-term at less than 28 weeks' gestation, currently aged 6-9 years, with and without BPD will be included.
- need for oxygen at 36 weeks' postmenstrual age, which includes those with moderate-severe disease .
- absence of any diagnosed pulmonary disease and term birth.
You may not qualify if:
- known interstitial lung disease, congenital lung anomalies, cystic fibrosis, ciliary dysfunction, immunodeficiency, neuromuscular disease or structural heart disease, which may have associated pulmonary function tests (PFT) and/or MRI findings;
- genetic syndromes which may have other associated structural lung anomalies;
- any contraindications for MRI
- severe neurosensory deficits which would prevent test completion;
- viral or bacterial respiratory infection within 6 weeks will be excluded. For all three groups (healthy, preterm non-BPD and preterm BPD), we will exclude
- those with congenital lung disease (i.e. Congenital diaphragmatic hernia (CDH), lung cysts) or non BPD acquired chronic lung disease as defined by need for any routine supplementary oxygen
- if the participant has an MRI incompatible device or any metal in their body which cannot be removed, including but not limited to pacemakers, neurostimulators, biostimulators, implanted insulin pumps, aneurysm clips, bio prosthetic, artificial limb, metallic fragment or foreign body, shunt, surgical staples (including clips or metallic sutures and/or ear implants).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Hospital for Sick Children
Toronto, Ontario, M5G 1X8, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Senior Scientist
Study Record Dates
First Submitted
February 6, 2018
First Posted
March 23, 2018
Study Start
September 1, 2018
Primary Completion
October 8, 2019
Study Completion
October 8, 2019
Last Updated
August 1, 2025
Record last verified: 2025-07
Data Sharing
- IPD Sharing
- Will not share
IPD will not be shared with other researchers outside of the institutions